Spina Bifida Awareness Week Designation

Summary#

Florida House Resolution 8117, titled “Spina Bifida Awareness Week,” designates October 18–24, 2026, as Spina Bifida Awareness Week in Florida. It is a resolution, not a bill that amends an existing Act or creates a new program; its stated goal is to raise awareness.

  • The resolution makes the designation, but does not require anyone to hold events or take other action.
  • It does not create a benefit, fee, fine, service, or enforcement power.
  • The resolution’s background statements cite folic acid intake as a way to help prevent neural tube defects and say some Florida counties report higher rates. Those statements are not new legal requirements.

What it means for you#

  • Florida residents and organizations: The week is designated for awareness, but the resolution does not require you to participate or provide anything.
  • People with spina bifida and their families: The resolution does not create new medical services, financial assistance, or other direct support.

Money#

No cost information is provided for the resolution itself.

  • The resolution cites an estimate of up to $800,000 in lifetime care costs for one person with spina bifida. That is background information, not spending authorized by this resolution.
  • No funding, staffing, fees, or savings are specified.

What is unclear#

  • No publicly available information in the supplied material says whether any events or public information efforts will accompany the designation.
  • The resolution sets no measures for tracking whether awareness changes or health outcomes follow.

Case for#

  • A possible argument for the resolution is that a designated week could give Floridians a focus for sharing information about spina bifida and prevention.
  • The resolution links folic acid intake to preventing neural tube defects and cites ongoing cases in Florida.

Case against#

  • One concern is that designation alone does not require public information efforts or provide services to people with spina bifida.
  • It is unclear whether the designation will lead to any specific action or how its effects would be measured.